首页> 外文期刊>Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus >Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
【24h】

Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma

机译:对食管鳞状细胞癌患者进行Neoadjuvant ChemoraMathiation后对病理完全反应预测的载体的开发

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Nomograms incorporating multiple prognostic factors are useful for individualized estimation of survival in cancer patients. However, nomograms for the prediction of pathological complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in patients with esophageal cancer are scarce. Here, we describe the development of a nomogram for predicting pCR after nCRT in patients with esophageal squamous cell carcinoma (ESCC). We retrospectively reviewed the records of 392 ESCC patients who underwent nCRT followed by esophagectomy. Seventy percent of the participants (n=274) were randomly assigned to a training cohort, whereas the remaining 30% were included in a validation cohort (n=118). Data from the training cohort were subjected to multivariate logistic regression analyses for selecting variables to be included in the nomogram. The performance of the resulting nomogram was internally and externally validated by calculating the bias-corrected concordance statistic (c-statistic) and the area under the receiver operating characteristics curve (AUROC) in the training and validation cohorts, respectively. After surgery, 25.77% of the study patients achieved pCR. The following variables were included in the nomogram: (i) age, (ii) pretreatment tumor length, (iii) history of head and neck cancer, (iv) post-nCRT albumin levels, and (v) post-nCRT endoscopic findings coupled with endoscopic biopsy results. The bias-corrected c-statistic and AUROC of the internal and external validation sets were 0.77 and 0.747, respectively. Our nomogram showed a good performance for predicting pCR after nCRT in ESCC patients.
机译:包含多个预后因素的载体图对于癌症患者的个性化估算是有用的。然而,在食管癌患者患者中新辅助化学疗法(NCRT)后,对病理完全反应(PCR)预测的载体是稀缺的。在这里,我们描述了在食管鳞状细胞癌(ESCC)患者中NCRT后预测PCR的NOM图的发展。我们回顾性地审查了接受NCRT的392名ESCC患者的记录,然后是食道切除术。将70%的参与者(n = 274)随机分配给培训队列,而剩余的30%包括在验证队列(n = 118)中。来自培训队群的数据进行多元逻辑回归分析,用于选择要包含在墨迹图中的变量。通过计算训练和验证队列中的接收器操作特性曲线(AUROC)下的偏置纠正的一致性统计(C统计)和地区,通过计算所得NOM图的性能。手术后,25.77%的研究患者达到了PCR。下面的变量包括在Nom:(i)年龄,(ii)预处理肿瘤长度,(iii)头颈癌的历史(IV)后Ncrt白蛋白水平,(v)后Ncrt内窥镜发现耦合具有内窥镜活组织检查结果。内部和外部验证集的偏置C统计和氧化菌分别为0.77和0.747。我们的NOM图显示出在ESCC患者NCRT后预测PCR的良好表现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号